Current Practices And Barriers In HRD And BRCA Testing For Ovarian Cancer: Preliminary Findings From The European Network Of Young Gynaecologic Oncologists (ENYGO) Cross-Sectional Study
Houssein El-Hajj(Institut Gustave Roussy), Tibor A. Zwimpfer(University Hospital of Basel), Martina Aida Ángeles(Hospital Sant Joan de Déu Barcelona), Zoia Razumova(Karolinska Institutet), Stamatios Petousis(Aristotle University of Thessaloniki), Alejandra Martínez(Institut universitaire du cancer de Toulouse Oncopole), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Aleksandra Strojna(Kliniken Essen-Mitte), Nicolò Bizzarri(Agostino Gemelli University Polyclinic), İlker Kahramanoğlu(Biruni University), Viola Heinzelmann‐Schwarz(Roche (Switzerland)), Maria Kfoury(Institut Gustave Roussy), Joanna Kacperczyk‐Bartnik(Medical University of Warsaw), Andrea Rosati(Agostino Gemelli University Polyclinic), Matteo Lambertini(Ospedale Policlinico San Martino), Giuseppe Caruso(University of Siena), Frédéric Amant(The Netherlands Cancer Institute), Khayal Gasimli(Goethe University Frankfurt), Esra Bilir(Koç University)
Cited by 1
Related Papers
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Cancer and fertility preservation: international recommendations from an expert meeting
|BMC Medicine|2016|779
Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy
|New England Journal of Medicine|2015|371
Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of Cytology
|The Journal of Clinical Endocrinology & Metabolism|2010|316
Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting
|Annals of Oncology|2019|276